In a world where artificial intelligence, climate change, epidemics and more compete for our concern, the need for people who can weigh the technical and humanistic sides of an argument is crucial. A…
Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date